Reply to "breakpoints and drug exposure are inevitably closely linked"

Systematic and quantitative analyses of hollow fiber model of Mycobacterium abscessus lung disease studies and new dosing recommendations.

Microbiology spectrum·2026

Novel regimens for treatment of Mycobacterium avium lung disease based on advanced in vitro systems and the mathematics of basis functions.

bioRxiv : the preprint server for biology·2026

Sulbactam-durlobactam plus ceftriaxone dosing and novel treatment regimens for Mycobacterium abscessus lung disease.

Antimicrobial agents and chemotherapy·2026

Population-based study of pharmacogenetics and pharmacokinetics in Southern African patients with multidrug-resistant tuberculosis (PoPG): a protocol for the Namibian cohort.

BMJ open·2026

Preclinical pharmacokinetics/pharmacodynamics studies defining the role of ethambutol in Mycobacterium kansasii lung disease.

Antimicrobial agents and chemotherapy·2025

Efficacy of isoniazid in paediatric tuberculosis: an individual participant data meta-analysis.

The European respiratory journal·2025

A chloramine-based antiseptic polymer improves Candida auris skin decolonization compared to chlorhexidine in a murine model.

Antimicrobial agents and chemotherapy·2026

Fluoroquinolone resistance-conferring gyrA variants alter the fitness cost and potentiate the resistance of the zoliflodacin resistance mutation gyrBD429N in Neisseria gonorrhoeae.

Antimicrobial agents and chemotherapy·2026

In vivo emergence of ceftazidime/avibactam resistance in Pseudomonas aeruginosa driven by OXA-1381, a novel W157L Ω-loop variant of OXA-2.

Antimicrobial agents and chemotherapy·2026

Antifungal activity of the nucleoside mimetic 5-fluorouridine against Candidozyma auris and Candida species.

Antimicrobial agents and chemotherapy·2026

Antibacterial and antivirulence activities of abafungin against Clostridioides difficile: in vitro and in vivo studies.

Antimicrobial agents and chemotherapy·2026

Emergence and local dissemination of NDM-14-producing Klebsiella pneumoniae ST147: a phylodynamic and epidemiological investigation.

Antimicrobial agents and chemotherapy·2026

Successful rescue of a patient with extensive lethal-dose aluminum phosphide poisoning complicated by multiple organ dysfunction syndrome.

The Journal of international medical research·2026

Duloxetine ameliorates acute pancreatitis-associated inflammation and modulates pain related neuroinflammatory pathways via modulation of SP-related neurokinin signaling and PAR2/TRPV1 pathways.

Frontiers in toxicology·2026

Effect of pentoxifylline on inflammatory markers in non-diabetic chronic kidney disease patients: A prospective, interventional, open label.

World journal of nephrology·2026

Comparison of propofol alone vs propofol-phenylephrine combination for intraoperative hemodynamic stability in glioma surgery.

World journal of methodology·2026

[Efficacy and safety of H. pylori eradication therapy in real-world clinical practice: results of the «PAMIR» observational program].

Terapevticheskii arkhiv·2026

NAD+ supplementation and PARP inhibition following spinal cord injury in mice: Hurdles and considerations for therapeutic use.

Spinal cord·2026

Related Experiment Videos

Reply to "breakpoints and drug exposure are inevitably closely linked"

Related Concept Videos

Systematic and quantitative analyses of hollow fiber model of Mycobacterium abscessus lung disease studies and new dosing recommendations.

Novel regimens for treatment of Mycobacterium avium lung disease based on advanced in vitro systems and the mathematics of basis functions.

Sulbactam-durlobactam plus ceftriaxone dosing and novel treatment regimens for Mycobacterium abscessus lung disease.

Population-based study of pharmacogenetics and pharmacokinetics in Southern African patients with multidrug-resistant tuberculosis (PoPG): a protocol for the Namibian cohort.

Preclinical pharmacokinetics/pharmacodynamics studies defining the role of ethambutol in Mycobacterium kansasii lung disease.

Efficacy of isoniazid in paediatric tuberculosis: an individual participant data meta-analysis.

A chloramine-based antiseptic polymer improves Candida auris skin decolonization compared to chlorhexidine in a murine model.

Fluoroquinolone resistance-conferring gyrA variants alter the fitness cost and potentiate the resistance of the zoliflodacin resistance mutation gyrBD429N in Neisseria gonorrhoeae.

In vivo emergence of ceftazidime/avibactam resistance in Pseudomonas aeruginosa driven by OXA-1381, a novel W157L Ω-loop variant of OXA-2.

Antifungal activity of the nucleoside mimetic 5-fluorouridine against Candidozyma auris and Candida species.

Antibacterial and antivirulence activities of abafungin against Clostridioides difficile: in vitro and in vivo studies.

Emergence and local dissemination of NDM-14-producing Klebsiella pneumoniae ST147: a phylodynamic and epidemiological investigation.

Successful rescue of a patient with extensive lethal-dose aluminum phosphide poisoning complicated by multiple organ dysfunction syndrome.

Duloxetine ameliorates acute pancreatitis-associated inflammation and modulates pain related neuroinflammatory pathways via modulation of SP-related neurokinin signaling and PAR2/TRPV1 pathways.

Effect of pentoxifylline on inflammatory markers in non-diabetic chronic kidney disease patients: A prospective, interventional, open label.

Comparison of propofol alone vs propofol-phenylephrine combination for intraoperative hemodynamic stability in glioma surgery.

[Efficacy and safety of H. pylori eradication therapy in real-world clinical practice: results of the «PAMIR» observational program].

NAD+ supplementation and PARP inhibition following spinal cord injury in mice: Hurdles and considerations for therapeutic use.

Related Experiment Videos

Reply to "breakpoints and drug exposure are inevitably closely linked"

Related Concept Videos

Related Articles